title: Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions.
authors.affiliation: Office of Medical Policy, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Robb
authors.affiliation: National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.
authors.forename: Pamela M
authors.initials: PM
authors.lastname: McInnes
authors.affiliation: US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
mesh_terms: D015415:Biomarkers; D032921:Consensus; D004864:Equipment and Supplies; D005819:Genetic Markers; D009316:National Institutes of Health (U.S.); D004364:Pharmaceutical Preparations; D009626:Terminology as Topic; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D015415:Biomarkers; D005819:Genetic Markers; D004364:Pharmaceutical Preparations